Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-12-20Clinical Trial Update: Dose Escalation Trial of Tefinostat for Cancer Associated Inflamation in Hepatocellular Carcinoma (HCC) [Phase 1, Phase 2]
A dose-escalation trial of tefinostat for cancer-associated inflammation in hepatocellular carcinoma is described (Phase 1/2).
-
CLINICAL_TRIALS trial_result · 2018-12-19Clinical Trial Update: Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating Mapatumumab in combination with Sorafenib for advanced hepatocellular carcinoma has completed recruitment with re…
-
CLINICAL_TRIALS trial_result · 2018-12-13Clinical Trial Update: Dose Escalation Study for Primary Hepatocellular Carcinoma [NA]
A dose-escalation clinical trial for hepatocellular carcinoma has completed, with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-11-21Clinical Trial Update: A Study of Ramucirumab (LY3009806) in Participants With Advanced Liver Cancer [Phase 1]
Phase 1 trial update of ramucirumab (LY3009806) in participants with advanced hepatocellular carcinoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-11-20Clinical Trial Update: A Study to Assess the Efficacy and Safety of Enzalutamide in Subjects With Advanced Hepatocellular Carcinoma [Phase 2]
This update reports the completion of a Phase 2 trial evaluating enzalutamide for advanced hepatocellular carcinoma, with results posted in …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-11-16Clinical Trial Update: Study of PolyIC and PD-1 mAb in Subjects With Unresectable Hepatocellular Carcinoma [Phase 2]
Phase 2 clinical trial evaluating PolyIC in combination with a PD-1 monoclonal antibody for unresectable hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2018-10-31Clinical Trial Update: TAC-101 in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer) [Phase 1, Phase 2]
Clinical trial update for TAC-101 in advanced hepatocellular carcinoma, reporting Phase 1 and Phase 2 results.
-
CLINICAL_TRIALS trial_result · 2018-09-26Clinical Trial Update: PET/CT in Diagnosing Patients With Liver Cancer Undergoing Surgical Resection [Phase 2]
A Phase 2 clinical trial evaluating PET/CT for diagnosing patients with liver cancer who are undergoing surgical resection has completed, wi…
-
CLINICAL_TRIALS trial_result · 2018-09-25Clinical Trial Update: A Multicenter, Open-Label, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib (E7080) Versus Sorafenib in First-line Treatment of Participants With Unresectable Hepatocellular Carcinoma [Phase 3]
Phase 3 trial comparing lenvatinib to sorafenib as first-line therapy for unresectable hepatocellular carcinoma has completed; results were …
-
CLINICAL_TRIALS trial_result · 2018-09-11Clinical Trial Update: Palliative Treatments for Patients With Advanced Hepatocellular Carcinoma (HCC) [Phase 4]
Phase 4 clinical trial update on palliative treatments for advanced hepatocellular carcinoma, completed.
-
CLINICAL_TRIALS trial_result · 2018-09-04Clinical Trial Update: Phase Ib/2, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Hepatocellular Carcinoma [Phase 1, Phase 2]
Phase Ib/2 multicenter dose-escalation study of DCR-MYC in hepatocellular carcinoma was terminated, with results posted in September 2018.
-
CLINICAL_TRIALS trial_result · 2018-09-04Clinical Trial Update: Ph 2 Trial of ADI PEG 20 Plus Concurrent Transarterial Chemoembolization (TACE) Vs TACE Alone in Patients With Unresectable Hepatocellular Carcinoma [Phase 2]
Phase 2 trial evaluating ADI PEG 20 plus concurrent TACE versus TACE alone in unresectable hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2018-08-27Clinical Trial Update: Advanced Image Guidance Utilized in Liver Surgery [NA]
A completed clinical trial evaluating advanced image guidance in liver surgery for hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2018-08-23Clinical Trial Update: A Study of Vitamin C in the Treatment of Liver Cancer to Determine if it is Safe and Effective [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating high-dose vitamin C for safety and potential efficacy in metastatic hepatocellular carcinoma (advance…
-
CLINICAL_TRIALS trial_result · 2018-08-17Clinical Trial Update: TACE Combined With RFA/MV Treatment in Hepatocellular Carcinoma Beyond Milan Criterial [Phase 3]
Phase 3 clinical trial evaluating transarterial chemoembolization (TACE) combined with radiofrequency/multivessel (RFA/MV) treatment for hep…
-
CLINICAL_TRIALS trial_result · 2018-08-07Clinical Trial Update: Taiwan ACE Beads for Hepatoma Embolization Therapy [NA]
Clinical trial update for Taiwan ACE Beads used in hepatoma embolization therapy; study completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-08-02Clinical Trial Update: Neoadjuvant HAIC for Resectable Hepatocellular Carcinoma Beyond Milan Criteria [Phase 3]
Phase 3 trial update on neoadjuvant hepatic arterial infusion chemotherapy (HAIC) for resectable hepatocellular carcinoma beyond Milan crite…
-
CLINICAL_TRIALS trial_result · 2018-08-02Clinical Trial Update: Hepatectomy Versus Chemoembolization for Resectable Hepatocellular Carcinoma Beyond Milan Criteria [Phase 4]
Phase 4 trial comparing hepatectomy to chemoembolization for resectable hepatocellular carcinoma beyond Milan criteria; status of the study …
-
CLINICAL_TRIALS trial_result · 2018-07-31Clinical Trial Update: A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies [Phase 1, Phase 2]
A Phase 1/2 clinical trial is investigating cannabidiol for efficacy in multiple myeloma, glioblastoma, and various gastrointestinal cancers…
-
CLINICAL_TRIALS research · 2018-07-27Clinical Trial Update: Effectivity and Safety of Ultrasound-guided Percutaneously Radiofrequency Ablation for Liver Cancer [Phase 1, Phase 2]
This update discusses a Phase 1/2 clinical trial evaluating the effectiveness and safety of ultrasound-guided percutaneous radiofrequency ab…
-
CLINICAL_TRIALS trial_result · 2018-07-26Clinical Trial Update: A Trial of SHR-1210 in Combination With SHR6390 in Patients With Advanced CRC, NSCLC and HCC [Phase 1, Phase 2]
A clinical trial update for SHR-1210 in combination with SHR6390 in patients with advanced colorectal cancer, non-small cell lung cancer, an…
-
CLINICAL_TRIALS research · 2018-07-20Clinical Trial Update: Effect of Remote Ischaemic preConditioning on Liver Injury in Patients Undergoing LIVER Resection Surgery [NA]
Clinical trial update evaluating whether remote ischemic preconditioning reduces liver injury in patients undergoing liver resection for hep…
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: Chemoembolization Using Doxorubicin in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery [NA]
This clinical trial update notes the completion of a trial evaluating chemoembolization with doxorubicin for unresectable liver cancer, with…
-
CLINICAL_TRIALS research · 2018-07-12Clinical Trial Update: Nursing Fro Laparoscopic vs. Open Hepatectomy
An ongoing clinical trial comparing laparoscopic versus open hepatectomy for liver cancer, with the study status currently unknown.
-
CLINICAL_TRIALS trial_result · 2018-07-11Clinical Trial Update: 3-Tesla MRI Response to TACE in HCC (Liver Cancer) [NA]
Clinical trial update noting 3-Tesla MRI responses to transarterial chemoembolization in hepatocellular carcinoma, with the study terminated…